Red blood cells inspire next-generation therapeutic nanocarriers
Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments. Scientists at The Ohio State University have showed that the engineered extracellular vesicles could evade immune cells and target cancer cells, two capabilities that could improve the delivery of future therapies. The study is published in Advanced Healthcare Materials.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Children's lung capacity caught up with their peers in less polluted areas once a clean air zone came in, a study shows.
The procedure was carried out last week at a hospital in Sri Lanka, with the stone weighing over three kilograms.
Cancer survivor fights for egg preservation fertility treatment
A benign but invasive canine oral cancer is often mistaken for a similar malignant one, leading to misdiagnoses in close…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →